Amidst an unprecedented fall in the EBITDA margins of Fortis, whether its two bidders can revive the company's operations is a million dollar question.
Missed your morning newspaper? Rushing to get to office? ThePrint has the daily news covered for you. From national headlines to opinions and business news, this is all that India's papers are reporting today.
The founders had taken at least 5 billion rupees of Fortis Healthcare’s cash without board approval. The market regulator, and India’s Serious Fraud Investigation Office, are looking into the company and auditors have refused to certify financial results.
Fortis is discussing issuing around 40 billion rupees ($615 million) of new stock to TPG and Manipal through a preferential allotment, one of the people said.
One has to be incredibly credulous to buy BJP spin masters’ argument that the government got rid of Vice President Jagdeep Dhankhar for harmonious relationship with the judiciary.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
Capable of being fired in plain and high-altitude areas, it has day-and-night capability and two-way data link to support post-launch target, aim-point update.
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
Ranbaxy, once one of India’s most trusted brands in pharmaceuticals, proved a lemon for its Japanese buyers, Dai ichi, who sold it later to Sun Pharmaceuticals. There was a lot of fudging in that transaction, for which the Brothers Singh are still trying to wriggle out of responsibility. They would have prospered more if they had practised a higher standard of corporate governance.
I fail to understand why an insurance is necessary at all. If I am sick I go to a doctor and pay his charges. Cut the Insurance Co to its size.
Ranbaxy, once one of India’s most trusted brands in pharmaceuticals, proved a lemon for its Japanese buyers, Dai ichi, who sold it later to Sun Pharmaceuticals. There was a lot of fudging in that transaction, for which the Brothers Singh are still trying to wriggle out of responsibility. They would have prospered more if they had practised a higher standard of corporate governance.